- Home
- LPTX vs HCTI Comparison
LPTX vs HCTI Comparison
Compare LPTX & HCTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- HCTI
- Stock Information
- Founded
- LPTX 2011
- HCTI 2020
- Country
- LPTX United States
- HCTI United States
- Employees
- LPTX N/A
- HCTI N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- HCTI Retail: Computer Software & Peripheral Equipment
- Sector
- LPTX Health Care
- HCTI Technology
- Exchange
- LPTX Nasdaq
- HCTI Nasdaq
- Market Cap
- LPTX 14.7M
- HCTI 13.5M
- IPO Year
- LPTX N/A
- HCTI 2021
- Fundamental
- Price
- LPTX $0.31
- HCTI $3.09
- Analyst Decision
- LPTX Hold
- HCTI
- Analyst Count
- LPTX 1
- HCTI 0
- Target Price
- LPTX N/A
- HCTI N/A
- AVG Volume (30 Days)
- LPTX 661.1K
- HCTI 2.7M
- Earning Date
- LPTX 08-19-2025
- HCTI 08-18-2025
- Dividend Yield
- LPTX N/A
- HCTI N/A
- EPS Growth
- LPTX N/A
- HCTI N/A
- EPS
- LPTX N/A
- HCTI N/A
- Revenue
- LPTX N/A
- HCTI $11,291,000.00
- Revenue This Year
- LPTX N/A
- HCTI N/A
- Revenue Next Year
- LPTX N/A
- HCTI N/A
- P/E Ratio
- LPTX N/A
- HCTI N/A
- Revenue Growth
- LPTX N/A
- HCTI N/A
- 52 Week Low
- LPTX $0.22
- HCTI $1.37
- 52 Week High
- LPTX $4.79
- HCTI $473.10
- Technical
- Relative Strength Index (RSI)
- LPTX 43.86
- HCTI 39.56
- Support Level
- LPTX $0.30
- HCTI $2.78
- Resistance Level
- LPTX $0.37
- HCTI $3.60
- Average True Range (ATR)
- LPTX 0.03
- HCTI 2.97
- MACD
- LPTX -0.00
- HCTI -0.57
- Stochastic Oscillator
- LPTX 28.53
- HCTI 1.64
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.
About HCTI Healthcare Triangle Inc.
Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.